Do antiepileptic drugs differ in suppressing interictal epileptiform activity in children?

被引:22
作者
Libenson, MH
Caravale, B
机构
[1] Floating Hosp Children, New England Med Ctr, Div Pediat Neurol, Dept Pediat, Boston, MA 02111 USA
[2] Floating Hosp Children, New England Med Ctr, Div Pediat Neurol, Dept Neurol, Boston, MA 02111 USA
[3] Tufts Univ, Sch Med, Boston, MA 02111 USA
关键词
D O I
10.1016/S0887-8994(00)00271-X
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Antiepileptic drugs may suppress interictal epileptiform activity in addition to suppressing seizures, although the comparative rates of suppression of interictal epileptiform activity for phenobarbital (PHB), carbamazepine (CBZ), and valproate (VPA) in children are unknown. Electroencephalogram (EEG) pairs were identified in which the first tracing illustrated interictal epileptiform activity before antiepileptic drug treatment; the rate of clearance of such activity in the subsequent tracing was assessed according to the drug introduced. EEG pairs (n = 213) were identified for CBZ, PHB, and VPA. Overall suppression rates of epileptiform activity in the second EEG were 12/55 (22%) for PHB, 27/81 (33%) for CBZ, and 35/77 (46%) for VPA (P = 0.005 for VPA vs PHB). When suppression rates were assessed comparing sleep-state pairs, suppression rates were 24/80 (30%) for PHB, 51/129 (40%) for CBZ, and 60/120 (50%) for VPA (P = 0.005 for PHB vs VPA). A subanalysis for focal discharges yielded suppression rates of 10/43 (23%) for PHB, 19/60 (32%) for CBZ, and 8/19 (42%) for VPA; for generalized discharges, 2/12 (17%) for PHB, 8/21 (38%) for CBZ, and 27/58 (47%) for VPA. VPA, and to a lesser extent CBZ, appeared superior to PHB in suppressing interictal epileptiform activity, including both focal and generalized epileptiform activity. (C) 2001 by Elsevier Science Inc. All rights reserved.
引用
收藏
页码:214 / 218
页数:5
相关论文
共 12 条
[1]   SODIUM VALPROATE IN TREATMENT OF INTRACTABLE SEIZURE DISORDERS - CLINICAL AND ELECTROENCEPHALOGRAPHIC STUDY [J].
ADAMS, DJ ;
LUDERS, H ;
PIPPENGER, C .
NEUROLOGY, 1978, 28 (02) :152-157
[2]   RELATION OF EEG AND SEIZURES TO PHENOBARBITAL IN SERUM [J].
BUCHTHAL, F ;
SVENSMARK, O ;
DIMONSEN, H .
ARCHIVES OF NEUROLOGY, 1968, 19 (06) :567-+
[3]   ANTIEPILEPTIC DRUGS AND THE ELECTROENCEPHALOGRAM [J].
DUNCAN, JS .
EPILEPSIA, 1987, 28 (03) :259-266
[4]   VALPROATE SODIUM - CONTROLLED CLINICAL-TRIAL INCLUDING MONITORING OF DRUG LEVELS [J].
GRAM, L ;
WULFF, K ;
RASMUSSEN, KE ;
FLACHS, H ;
WURTZJORGENSEN, A ;
SOMMERBECK, KW ;
LOHREN, V .
EPILEPSIA, 1977, 18 (02) :141-148
[5]  
HARDING GFA, 1978, EPILEPSIA, V19, P555, DOI 10.1111/j.1528-1157.1978.tb05036.x
[6]  
KELLAWAY P, 1978, ANN NEUROL, V4, P197
[7]  
Marciani M G, 1993, Int J Neurosci, V70, P107, DOI 10.3109/00207459309000566
[8]  
Meinardi H, 1985, Electroencephalogr Clin Neurophysiol Suppl, V37, P201
[9]   EFFECTS OF CARBAMAZEPINE ON PATIENTS WITH PSYCHOMOTOR EPILEPSY - RESULTS OF A DOUBLE-BLIND STUDY [J].
RODIN, EA ;
RIM, CS ;
RENNICK, PM .
EPILEPSIA, 1974, 15 (04) :547-561
[10]   SODIUM VALPROATE - SERIAL MONITORING OF EEG AND SERUM LEVELS [J].
ROWAN, AJ ;
BINNIE, CD ;
DEBEERPAWLIKOWSKI, NKB ;
GOEDHART, DM ;
GUTTER, T ;
VANDERGEEST, P ;
MEINARDI, H ;
MEIJER, JWA .
NEUROLOGY, 1979, 29 (11) :1450-1459